Your browser doesn't support javascript.
loading
Epidemiology and complications of anaesthesia in the French centres that participated to NECTARINE: A secondary analysis.
Dahmani, Souhayl; Laffargue, Anne; Dadure, Christophe; De Queiroz, Mathilde; Julien-Marsollier, Florence; Michelet, Daphné; Veyckemans, Francis; Amory, Catherine; Ludot, Hugues; Bert, Dina; Godart, Juliette; Laffargue, Anne; Dupont, Hervé; Urbina, Benjamin; Baujard, Catherine; Roulleau, Philippe; Staiti, Giuseppe; Bordes, Maryline; Nouette Gaulain, Karine; Hamonic, Yann; Semjen, François; Jacqmarcq, Olivier; Lejus-Bourdeau, Caroline; Magne, Cécile; Petry, Léa; Ros, Lilica; Zang, Aurélien; Bennis, Mehdi; Coustets, Bernard; Fesseau, Rose; Constant, Isabelle; Khalil, Eliane; Sabourdin, Nada; Audren, Noémie; Descarpentries, Thomas; Fabre, Fanny; Legrand, Aurélien; Druot, Emilie; Orliaguet, Gilles; Sabau, Lucie; Uhrig, Lynn; De La Briere, François; Jonckheer, Karin; Mission, Jean-Paul; Scordo, Lucia; Couchepin, Caroline; Dadure, Christophe; De La Arena, Pablo; Hertz, Laurent; Pirat, Philippe.
Affiliation
  • Dahmani S; French NECTARINE Trial Group, France; Paris Diderot University (Paris VII), Paris, France; Department of Anaesthesia and Intensive Care, Robert Debré University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France; FHU I2-D2, INSERM U1141, Robert Debré University Hospital, Paris, France.
  • Laffargue A; Department of Anaesthesia and Intensive Care, Jeanne de Flandre University Hospital, Lille, France.
  • Dadure C; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France; Institut de Neurosciences de Montpellier, Unité INSERM U1051, Montpellier, France.
  • De Queiroz M; Department of Anaesthesia and Intensive Care, University Hospital of Lyon, Lyon, France.
  • Julien-Marsollier F; French NECTARINE Trial Group, France; Paris Diderot University (Paris VII), Paris, France; Department of Anaesthesia and Intensive Care, Robert Debré University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France; FHU I2-D2, INSERM U1141, Robert Debré University Hospital, Paris, France.
  • Michelet D; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Robert Debré University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France; Department of Anaesthesia and Intensive Care, University Hospital of Reims, Reims, France.
  • Veyckemans F; Department of Anaesthesia and Intensive Care, Jeanne de Flandre University Hospital, Lille, France.
  • Amory C; French NECTARINE Trial Group, France; American Memorial Hospital CHU Reims, Reims, France.
  • Ludot H; French NECTARINE Trial Group, France; American Memorial Hospital CHU Reims, Reims, France.
  • Bert D; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Jeanne de Flandre University Hospital, Lille, France.
  • Godart J; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Jeanne de Flandre University Hospital, Lille, France.
  • Laffargue A; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Jeanne de Flandre University Hospital, Lille, France.
  • Dupont H; French NECTARINE Trial Group, France; CHU Amiens Picardie, Amiens, France.
  • Urbina B; French NECTARINE Trial Group, France; CHU Amiens Picardie, Amiens, France.
  • Baujard C; French NECTARINE Trial Group, France; CHU Bicêtre, Le Kremlin-Bicêtre, France.
  • Roulleau P; French NECTARINE Trial Group, France; CHU Bicêtre, Le Kremlin-Bicêtre, France.
  • Staiti G; French NECTARINE Trial Group, France; CHU Bicêtre, Le Kremlin-Bicêtre, France.
  • Bordes M; French NECTARINE Trial Group, France; CHU de Bordeaux, Bordeaux, France.
  • Nouette Gaulain K; French NECTARINE Trial Group, France; CHU de Bordeaux, Bordeaux, France.
  • Hamonic Y; French NECTARINE Trial Group, France; CHU de Bordeaux, Bordeaux, France.
  • Semjen F; French NECTARINE Trial Group, France; CHU de Bordeaux, Bordeaux, France.
  • Jacqmarcq O; French NECTARINE Trial Group, France; CHU de Nantes, Nantes, France.
  • Lejus-Bourdeau C; French NECTARINE Trial Group, France; CHU de Nantes, Nantes, France.
  • Magne C; French NECTARINE Trial Group, France; CHU de Nantes, Nantes, France.
  • Petry L; French NECTARINE Trial Group, France; CHU Nancy, Nancy, France.
  • Ros L; French NECTARINE Trial Group, France; CHU Nancy, Nancy, France.
  • Zang A; French NECTARINE Trial Group, France; CHU Nancy, Nancy, France.
  • Bennis M; French NECTARINE Trial Group, France; CHU Toulouse, Toulouse, France.
  • Coustets B; French NECTARINE Trial Group, France; CHU Toulouse, Toulouse, France.
  • Fesseau R; French NECTARINE Trial Group, France; CHU Toulouse, Toulouse, France.
  • Constant I; French NECTARINE Trial Group, France; Hôpital Armand-Trousseau AP-HP, Paris, France.
  • Khalil E; French NECTARINE Trial Group, France; Hôpital Armand-Trousseau AP-HP, Paris, France.
  • Sabourdin N; French NECTARINE Trial Group, France; Hôpital Armand-Trousseau AP-HP, Paris, France.
  • Audren N; French NECTARINE Trial Group, France; Hôpital couple enfant, CHU Grenoble Alpes, Grenoble, France.
  • Descarpentries T; French NECTARINE Trial Group, France; Hôpital couple enfant, CHU Grenoble Alpes, Grenoble, France.
  • Fabre F; French NECTARINE Trial Group, France; Hôpital couple enfant, CHU Grenoble Alpes, Grenoble, France.
  • Legrand A; French NECTARINE Trial Group, France; Hôpital couple enfant, CHU Grenoble Alpes, Grenoble, France.
  • Druot E; French NECTARINE Trial Group, France; Hôpital Universitaire Necker Enfants Malades, Paris, France.
  • Orliaguet G; French NECTARINE Trial Group, France; Hôpital Universitaire Necker Enfants Malades, Paris, France.
  • Sabau L; French NECTARINE Trial Group, France; Hôpital Universitaire Necker Enfants Malades, Paris, France.
  • Uhrig L; French NECTARINE Trial Group, France; Hôpital Universitaire Necker Enfants Malades, Paris, France.
  • De La Briere F; French NECTARINE Trial Group, France; Fondation Lenval - Hôpital pour enfants, Nice, France.
  • Jonckheer K; French NECTARINE Trial Group, France; Fondation Lenval - Hôpital pour enfants, Nice, France.
  • Mission JP; French NECTARINE Trial Group, France; Fondation Lenval - Hôpital pour enfants, Nice, France.
  • Scordo L; French NECTARINE Trial Group, France; Fondation Lenval - Hôpital pour enfants, Nice, France.
  • Couchepin C; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France.
  • Dadure C; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France.
  • De La Arena P; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France.
  • Hertz L; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France.
  • Pirat P; French NECTARINE Trial Group, France; Department of Anaesthesia and Intensive Care, Lapeyronie University Hospital, Montpellier, France.
Anaesth Crit Care Pain Med ; 41(2): 101036, 2022 04.
Article in En | MEDLINE | ID: mdl-35181529
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anesthesia Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Infant / Newborn Country/Region as subject: Europa Language: En Journal: Anaesth Crit Care Pain Med Year: 2022 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anesthesia Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Infant / Newborn Country/Region as subject: Europa Language: En Journal: Anaesth Crit Care Pain Med Year: 2022 Type: Article Affiliation country: France